Paclitaxel Plus Carboplatin Is Reportedly Non-Inferior to Paclitaxel and Ifosfamide in Uterine Carcinosarcoma
January 13, 2022 8:49 amby Ariana Pelosci
Findings from a phase 3 study indicated that patients with uterine carcinosarcoma treated with paclitaxel and carboplatin experienced a better progression-free survival and non-inferior duration of overall survival vs paclitaxel plus ifosfamide.
A combination regimen of paclitaxel
… Read more